Company intelligence / Profile preview

CCRM Nordic

Mölndal, Västra Götaland, Swedenccrmnordic.se ↗

Ownership: Private
Employees: ~13
Development stage: Other

Overview

CCRM Nordic is building state-of-the-art laboratory and GMP manufacturing facilities in Mölndal, Sweden to support the translation and commercialization of cell and gene therapies. It provides expertise in process development, analytics, business strategy, regulatory standards, and access to global industry networks. The organization does not develop its own therapeutics but accelerates the pipeline of client companies by providing critical infrastructure and services.

Modalities: Cell therapyGene therapyAdvanced Therapy Medicinal Products (ATMPs)
Industry: Contract Manufacturing Organization

Partnerships

SCTbio (strategic partnership for cGMP manufacturing services)AstraZeneca (innovation cluster member)CombiGene (innovation cluster member)Cytiva Sweden & Cytiva Testa CenterGetinge

Beyond the preview

Go deeper on CCRM Nordic.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CCRM Nordic.

Explore the full profile